QR Pharma, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
QR Pharma, Inc. - overview
Established
2008
Location
Berwyn, PA, US
Primary Industry
Pharmaceuticals
About
Founded in 2008 and based in Pennsylvania, US, QR Pharma, Inc. is a pharmaceutical company that develops Posiphen, a drug that prevents the formation of toxic proteins that causes neurodegenerative diseases such as Alzheimer's Disease and Parkinson's Disease.
Current Investors
Robin Hood Ventures, Ben Franklin Technology Partners, BioAdvance
Primary Industry
Pharmaceuticals
Sub Industries
Molecular Science, Genetics & Gene Therapy, Diagnostic, Medical & Imaging Laboratories, Pharmaceutical Research & Development
Website
www.qrpharma.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.